Curis | CRIS - Passivo Circulante





Passivo Circulante Alterar Data
Alaunos Therapeutics USD 921K 153K 2025-09
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
CSL USD 4.61B 207M 2025-12
Curis USD 14.08M 5.3M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Takeda JPY 2.61T 470.53B 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Verastem USD 72.27M 12.56M 2025-12
Xoma USD 28.3M 6.81M 2025-09